Paula Lum, MD, MPH

Photo of Paula Lum, MD, MPH

Email Paula
(415) 476-4082 x411

1001 Potrero Ave
San Francisco, CA 94110

Visit CTSI Profile

  • Professor, School of Medicine
  • Professor of Clinical Medicine and Program Director of the UCSF Primary Care Addiction Medicine Fellowship

Biography

Paula J. Lum, MD MPH is Professor of Clinical Medicine and Program Director of the UCSF Primary Care Addiction Medicine Fellowship. She has been a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital since 1999. Board certified in internal medicine and addiction medicine, Dr. Lum practices at the place where HIV, addiction, and poverty collide. Her research and clinical activities are grounded in evidence-based, patient-centered care to improve health outcomes and life quality of the urban poor. Her current areas of focus include: (1) HIV and viral hepatitis prevention and treatment in persons who inject drugs, (2) evidence-based interventions in primary care and non-traditional settings for substance use disorders and their complications, and (3) curricular interventions to provide health care professionals with the skills, knowledge, and confidence to offer effective patient-centered care to persons who use drugs.

Displaying 1 - 71 of 71

  1. Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, Korthuis PT. Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial. BMC Health Serv Res. 2019 Nov 21; 19(1):862. View on Pubmed
  2. Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study. Contemp Clin Trials. 2019 12; 87:105859. View on Pubmed
  3. Andrea L Cox, Kimberly Page, Michael Melia, Rebecca Veenhuis, Guido Massaccesi, William Osburn, Katherine Wagner, Linda Giudice, Ellen Stein, Alice K Asher, Ventzislav Vassilev, Lan Lin, Alfredo Nicosia, Stefania Capone, Elisa Scarselli, Antonella Folgori, Richard Gorman, Soju Chang, Peter Wolff, T Jake Liang, Marc Ghany, Michael Wierzbicki, Paula Lum. LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population. Open Forum Infectious Diseases. 2019 Oct 23; 6(Suppl 2):s997-s997. View on Pubmed
  4. Carter J, Zevin B, Lum PJ. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addict Sci Clin Pract. 2019 05 06; 14(1):20. View on Pubmed
  5. Satterfield JM, Gregorich SE, Kalkhoran S, Lum PJ, Bloome J, Alvarado N, Muñoz RF, Vijayaraghavan M. Computer-Facilitated 5A's for Smoking Cessation: A Randomized Trial of Technology to Promote Provider Adherence. Am J Prev Med. 2018 07; 55(1):35-43. View on Pubmed
  6. Mirzazadeh A, Evans JL, Hahn JA, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS Behav. 2018 04; 22(4):1383-1394. View on Pubmed
  7. Hettema JE, Cockrell SA, Reeves A, Ingersoll KS, Lum PJ, Saitz R, Murray-Krezan CM, Carrejo VA. Development and differentiability of three brief interventions for risky alcohol use that include varying doses of motivational interviewing. Addict Sci Clin Pract. 2018 02 27; 13(1):6. View on Pubmed
  8. Page K, Cox A, Lum PJ. Opioids, Hepatitis C Virus Infection, and the Missing Vaccine. Am J Public Health. 2018 02; 108(2):156-157. View on Pubmed
  9. Dawson-Rose C, Draughon JE, Cuca Y, Zepf R, Huang E, Cooper BA, Lum PJ. Changes in Specific Substance Involvement Scores among SBIRT recipients in an HIV primary care setting. Addict Sci Clin Pract. 2017 Dec 12; 12(1):34. View on Pubmed
  10. Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, Foley K, Leonard K, Treisman GJ, Selwyn P. 2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus. Clin Infect Dis. 2017 Oct 30; 65(10):1601-1606. View on Pubmed
  11. Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, Foley K, Leonard K, Treisman GJ, Selwyn P. 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clin Infect Dis. 2017 Oct 30; 65(10):e1-e37. View on Pubmed
  12. Simeone C, Shapiro B, Lum PJ. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic. Addict Sci Clin Pract. 2017 08 22; 12(1):19. View on Pubmed
  13. Kalkhoran S, Alvarado N, Vijayaraghavan M, Lum PJ, Yuan P, Satterfield JM. Patterns of and reasons for electronic cigarette use in primary care patients. J Gen Intern Med. 2017 Oct; 32(10):1122-1129. View on Pubmed
  14. Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. Int J Drug Policy. 2017 07; 45:64-69. View on Pubmed
  15. Vijayaraghavan M, Yuan P, Gregorich S, Lum P, Appelle N, Napoles AM, Kalkhoran S, Satterfield J. Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics. Prev Med Rep. 2017 Jun; 6:80-87. View on Pubmed
  16. Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction. 2017 Jun; 112(6):1036-1044. View on Pubmed
  17. Todd Korthuis, Paula J. Lum, P. Vergara-Rodriguez, Keith Ahamad, Evan Wood, R. Lindblad, Raul Mandler, James Sorensen, Doan Ha, Neal Oden, Lynn Kunkel, Dennis McCarty. Extended-release naltrexone feasibility in HIV clinics: A pilot study. Drug and Alcohol Dependence. 2017 Feb 1; 171:e108. View on Pubmed
  18. Ahamad K, Korthuis PT, Lum PJ, Johnson C, Wood E. A delayed injection-site reaction in a patient receiving extended-release naltrexone. Subst Abus. 2016 Apr-Jun; 37(2):278-80. View on Pubmed
  19. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. Am J Public Health. 2016 May; 106(5):915-7. View on Pubmed
  20. Paula J. Lum, R. Douglas Bruce. Comorbid substance use among persons with HIV and chronic pain. Chronic Pain and HIV. 2016 Mar 17; 78-96. View on Pubmed
  21. Dawson-Rose C, Draughon JE, Zepf R, Cuca YP, Huang E, Freeborn K, Lum PJ. Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening. J Assoc Nurses AIDS Care. 2017 Mar - Apr; 28(2):238-249. View on Pubmed
  22. Elise Riley, Judith A. Hahn, Jennifer L. Evans, Alya Briceno, Peter J. Davidson, Paula J. Lum, Kimberly Page. The longitudinal influence of multiple depressant use on nonfatal overdose among young people who inject drugs. Drug and Alcohol Dependence. 2015 Nov 1; 156:e190. View on Pubmed
  23. Kalkhoran S, Appelle NA, Napoles AM, Munoz RF, Lum PJ, Alvarado N, Gregorich SE, Satterfield JM. Beyond the Ask and Advise: Implementation of a Computer Tablet Intervention to Enhance Provider Adherence to the 5As for Smoking Cessation. J Subst Abuse Treat. 2016 Jan; 60:91-100. View on Pubmed
  24. Dawson Rose C, Cuca YP, Kamitani E, Eng S, Zepf R, Draughon J, Lum P. Using Interactive Web-Based Screening, Brief Intervention and Referral to Treatment in an Urban, Safety-Net HIV Clinic. AIDS Behav. 2015 Jun; 19 Suppl 2:186-93. View on Pubmed
  25. Soraya Azari, Neda Ratanawongsa, Jennifer Hettema, Caroline Cangelosi, Matt Tierney, Diana Coffa, Brad Shapiro, Sharad Jain, David Hersh, Jennifer Manuel, Daniel Ciccarone, Paula Lum. A Skills-Based Curriculum for Teaching Motivational Interviewing-Enhanced Screening, Brief Intervention, and Referral to Treatment (SBIRT) to Medical Residents. MedEdPORTAL. 2015 Jan 1. View on Pubmed
  26. Whittle AE, Buckelew SM, Satterfield JM, Lum PJ, O'Sullivan P. Addressing Adolescent Substance Use: Teaching Screening, Brief Intervention, and Referral to Treatment (SBIRT) and Motivational Interviewing (MI) to Residents. Subst Abus. 2015; 36(3):325-31. View on Pubmed
  27. Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014 Dec; 174(12):1974-81. View on Pubmed
  28. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014 May 29; 4(5):e004988. View on Pubmed
  29. Ratanawongsa N, Barton JL, Schillinger D, Yelin EH, Hettema JE, Lum PJ. Ethnically diverse patients' perceptions of clinician computer use in a safety-net clinic. J Health Care Poor Underserved. 2013 Nov; 24(4):1542-51. View on Pubmed
  30. McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict. 2014 Mar-Apr; 23(2):137-44. View on Pubmed
  31. Gruber VA, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. Interactions between alcohol and the HIV entry inhibitor Maraviroc. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):375-7. View on Pubmed
  32. McCance-Katz EF, Gruber VA, Beatty G, Lum PJ, Rainey PM. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med. 2013 Jul-Aug; 7(4):264-70. View on Pubmed
  33. Sara M. Buckelew, Amy Whittle, Paula Lum, Patricia O'Sullivan, Jason M. Satterfield. 8. Implementing Sbirt in Pediatrics: Results of a Needs Assessment. Journal of Adolescent Health. 2013 Feb 1; 52(2):s18-s19. View on Pubmed
  34. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013; 25(7):820-7. View on Pubmed
  35. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13. View on Pubmed
  36. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. . 2012 Jul 01; 60(3):282-8. View on Pubmed
  37. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8. View on Pubmed
  38. Hettema JE, Ratanawongsa N, Manuel JK, Ciccarone D, Coffa D, Jain S, Lum PJ. A SBIRT curriculum for medical residents: development of a performance feedback tool to build learner confidence. Subst Abus. 2012; 33(3):241-50. View on Pubmed
  39. Johnson MO, Dilworth SE, Stephens E, Lum PJ, Neilands TB. Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV. . 2011 Dec 15; 58(5):469-71. View on Pubmed
  40. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011 Aug 02; 11:208. View on Pubmed
  41. Asher A, Lum PJ, Page K. Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report. J Assoc Nurses AIDS Care. 2012 Jan-Feb; 23(1):16-29. View on Pubmed
  42. Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. . 2011 Mar 01; 56 Suppl 1:S33-8. View on Pubmed
  43. Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. . 2011 Mar 01; 56 Suppl 1:S22-32. View on Pubmed
  44. Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. . 2011 Mar 01; 56 Suppl 1:S83-90. View on Pubmed
  45. Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, Mitty J, Boverman J, Fiellin DA. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. . 2011 Mar 01; 56 Suppl 1:S91-7. View on Pubmed
  46. Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. . 2011 Mar 01; 56 Suppl 1:S54-61. View on Pubmed
  47. Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, Sierra E, Gatell JM, Page K, Joseph J. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine. 2011 Feb 24; 29(10):1991-6. View on Pubmed
  48. Rose CD, Courtenay-Quirk C, Knight K, Shade SB, Vittinghoff E, Gomez C, Lum PJ, Bacon O, Colfax G. HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people. . 2010 Dec 15; 55(5):572-81. View on Pubmed
  49. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51. View on Pubmed
  50. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64. View on Pubmed
  51. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26. View on Pubmed
  52. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009 May 01; 101(3):152-7. View on Pubmed
  53. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91. View on Pubmed
  54. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36. View on Pubmed
  55. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):43-50. View on Pubmed
  56. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007 Sep 12; 21(14):1967-9. View on Pubmed
  57. Colfax GN, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht FM. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007 Jan 11; 21(2):239-41. View on Pubmed
  58. Lum PJ, Tulsky JP. The medical management of opioid dependence in HIV primary care settings. Curr HIV/AIDS Rep. 2006 Nov; 3(4):195-204. View on Pubmed
  59. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. View on Pubmed
  60. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. . 2006 Jan 01; 41(1):31-6. View on Pubmed
  61. W. Kittikraisak, P. J. Davidson, J. A. Hahn, P. J. Lum, J. L. Evans, A. R. Moss, K. Page-Shafer. Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection. Journal of Substance Use. 2006 Jan 1; 11(4):271-281. View on Pubmed
  62. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005; 40(11):1681-96.
  63. Paula J. Lum, Kristen C. Ochoa, Judith A. Hahn, Kimberly Page Shafer, Jennifer L. Evans, Andrew R. Moss. LUM ET AL. RESPOND. American Journal of Public Health. 2004 Mar 1; 94(3):358-a-359.
  64. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health. 2003 Jun; 93(6):919-23.
  65. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46.
  66. Shafer KP, Hahn JA, Lum PJ, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. . 2002 Dec 01; 31(4):422-31.
  67. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 01; 186(11):1558-64.
  68. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul; 34(1):180-7.
  69. Clare Sears, Joseph R. Guydish, Erin K. Weltzien, Paula J. Lum. Investigation of a Secondary Syringe Exchange Program for Homeless Young Adult Injection Drug Users in San Francisco, California, U.S.A. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001 Jun 1; 27(2):193-201.
  70. Clare Sears, Joseph R. Guydish, Erin K. Weltzien, Paula J. Lum. Investigation of a Secondary Syringe Exchange Program for Homeless Young Adult Injection Drug Users in San Francisco, California, U.S.A. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001 Jun 1; 27(2):193.
  71. Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. . 2001 Jun 01; 27(2):193-201.